A Chinese regulator investigated Siemens AG very last year about irrespective of whether the German group’s healthcare device and its dealers bribed hospitals to acquire high priced disposable products and solutions made use of in some of its clinical devices, a few men and women with expertise of the probe instructed Reuters.
The investigation follows a vast-reaching probe into the pharmaceutical business in China that final year noticed GlaxoSmithKline fined just about $500 million for bribing officials to thrust its drugs income.
China’s State Administration for Sector and Commerce accused Siemens and its dealers of possessing violated level of competition law by donating clinical products in return for agreements to completely get the chemical reagents desired to run the machines from Siemens, the folks claimed.
A senior spokesman for Siemens in Germany claimed he was “not mindful” of the investigation and declined to remark on particular queries about the investigation.
Full content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Reserve Greenlights Capital One’s $35.3 Billion Acquisition of Discover
Apr 18, 2025 by
CPI
Google to Appeal Partial Ruling in DOJ Antitrust Case
Apr 18, 2025 by
CPI
Indian Ad Agencies Warned Against WhatsApp Discussions After Antitrust Raids
Apr 17, 2025 by
CPI
US Court Ruling Against Google Spurs Fresh Antitrust Tensions in Europe
Apr 17, 2025 by
CPI
AstraZeneca Accused of Stifling Biosimilar Competition for Rare Disease Drug
Apr 17, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – The Airline Industry
Apr 10, 2025 by
CPI
Boosting Competition in International Aviation
Apr 10, 2025 by
Jeffrey N. Shane
Reshaping Competition Policy for the U.S. Airline Industry
Apr 10, 2025 by
Diana L. Moss
Algorithmic Collusion in the Skies: The Role of AI in Shaping Airline Competition
Apr 10, 2025 by
Qi Ge, Myongjin Kim & Nicholas Rupp
Competition in U.S. Airline Markets: Major Developments and Economic Insights
Apr 10, 2025 by
Germán Bet